Veru Inc. $(VERU)$, a clinical stage biopharmaceutical company, announced a 1-for-10 reverse stock split of its common shares. This change will take effect on August 8, 2025, with trading on a split-adjusted basis starting August 11, 2025. The stock will continue to trade under the same symbol but with a new CUSIP number 92536C202. The reverse stock split will uniformly affect all shareholders, consolidating every 10 existing shares into one new share, while maintaining the same ownership percentage for each shareholder, except for adjustments for fractional shares.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Veru Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-25-026037), on August 12, 2025, and is solely responsible for the information contained therein.